What will Boston Pharmaceuticals CEO Sophie Kornowski do now that the company is selling off its pipeline and winding down operations? Whatever it is, data will take her there.

GLP-1 drugs came out in 2005 as a Type 2 diabetes treatment. But in recent years their popularity for weight loss -- and the cost -- has taken off.

Ending months of neighborhood speculation, Supervalu will close the long-struggling Midway Cub Foods store and its Cub ...

The Illinois General Assembly passed seven bills that expand the ability of professionals to work in Illinois. Lawmakers need ...

Caroline Vovan, PharmD, CDE, highlights how ambulatory clinical pharmacists contribute to value-based care by managing chronic conditions, improving medication adherence, and reducing costs.

The Government is introducing draft legislation to Parliament, which will update laws from 1933, which state that a ...

In response to a growing pharmacy technician shortage and oncology care demands, Moffitt Cancer Center in Tampa, Fla., developed and launched an in-house training program to help grow its pharmacy ...

A year after the launch of Pharmacy First, the scheme designed to speed up treatment for common conditions, this report sets out the results of a new poll of over 7,000 adults’ experience of using ...

New Orleans-based Ochsner Health is expanding its relationship with a company called Latent that it has partnered with to develop clinical AI tools to help with specialty, infusion, and retail ...

The pharmacist of tomorrow will function by reason of what he knows, increasing the efficiency and safety of drug therapy and working as a specialist in his own right.